Objective-To investigate the extent to which the detection of antibodies to gliadin, endomysium, and jejunum predicts the eventual diagnosis of coeliac disease according to the revised ESPGAN diagnostic criteria in a group of patients in whom there is a high suspicion of coeliac disease.
Introduction
In 1979 the European Society of Paediatric Gastroenterology and Nutrition recommended criteria for diagnosing coeliac disease.' Since then the accumulated knowledge of the clinical, pathological, and laboratory manifestations and of the practical aspects of management of this condition have led many to adopt a more flexible approach to diagnosis,2 and arising from this the society has recently revised its recommended criteria.3 These require characteristic small intestinal mucosal histology while the patient is eating normal amounts of gluten and unequivocal clinical remission after exclusion of gluten from the diet.
Much effort has been expended in attempting to develop reliable non-invasive means of diagnosing or at least simplifying the diagnosis of coeliac disease. Methods 
Discussion
We studied patients referred by their general practitioners to a hospital gastroenterology clinic in whom it was deemed appropriate to perform a jejunal biopsy because of a high suspicion of coeliac disease. The patients are therefore an important group in which to assess the discriminative value of antibody tests in coeliac disease.
Although some studies have reported similar predictive values, sensitivities, and specificities of antibody Testing for coeliac disease associated antibodies, particularly gliadin IgA by ELISA, promises to simplify and make more efficient the selection of patients for jejunal biopsy and perhaps in the not too distant future may allow the condition to be diagnosed with confidence without the need for biopsy. However, a similar high performance of this or some other assay would need to be shown in a less selected population before biopsy becomes unnecessary.
